Trump GLP-1 Prices: Costs for Wegovy, Ozempic, Zepbound, & Mounjaro

Last updated: October 17, 2026

Quick Answer

Trump GLP-1 prices now run through a mix of direct-to-consumer deals and government-negotiated rates. The TrumpRx.gov platform and Most-Favored-Nation agreements with Novo Nordisk and Eli Lilly have pushed cash-pay and Medicare prices for Wegovy, Ozempic, Zepbound, and Mounjaro well below their old list prices, though exact savings depend on dose, insurance status, and which purchasing channel you use [1][3][5].

Key Takeaways

• TrumpRx.gov launched in February 2026 as a direct federal portal connecting patients to lower-cost versions of GLP-1 drugs and other medications [1][5].
• Most-Favored-Nation pricing deals tie US prices closer to what other wealthy countries pay, covering Medicare, Medicaid, and some cash-pay options [3][7].
• Novo Nordisk and Eli Lilly have both committed to cutting list and cash prices for Wegovy, Ozempic, Zepbound, and Mounjaro through 2027 [3][9].
• Out-of-pocket costs still vary widely based on dose, pharmacy, insurance plan, and whether you qualify for manufacturer coupons [10].
• GLP-1 drugs work by mimicking gut hormones that slow digestion and reduce appetite, which is why they help with both diabetes and weight loss [2][4].
• Insurance coverage for weight-loss use remains inconsistent; diabetes use (Ozempic, Mounjaro) is covered more often than weight-loss use (Wegovy, Zepbound) [10].
• Common side effects include nausea, vomiting, and digestive upset, and the drugs are not recommended for people with certain thyroid cancer histories [2][4].

Trump GLP-1 Prices: Costs for Wegovy, Ozempic, Zepbound, & Mounjaro Explained

Trump GLP-1 prices reflect a direct federal push to lower what Americans pay for obesity and diabetes drugs through a new purchasing portal and manufacturer pricing agreements. The centerpiece is TrumpRx.gov, launched in February 2026, which the White House describes as a tool giving patients access to discounted cash prices for brand-name drugs, including GLP-1 medications, without going through traditional insurance channels [1][5].

Alongside the portal, the administration struck Most-Favored-Nation pricing agreements with Novo Nordisk and Eli Lilly in late 2025, aiming to bring US drug costs closer to prices charged in other developed countries [3][7]. These deals apply to Medicare and Medicaid pricing and, in some cases, extend to cash-pay patients buying directly through manufacturer or federal channels [3].

What this means in practice:

• TrumpRx.gov offers a federally brokered cash price for eligible drugs, bypassing some middleman markups [1].
• MFN agreements lower what Medicare and Medicaid pay, which can also pull down list prices over time [3][7].
• Manufacturer commitments from Novo Nordisk and Eli Lilly include planned wholesale price cuts that are expected to phase in further through 2027 [9].

Choose the TrumpRx.gov pathway if you’re uninsured or your plan doesn’t cover GLP-1 drugs for weight loss, since it’s built specifically for cash-pay patients seeking lower sticker prices [1][5].

What Are GLP-1 Drugs and How Do They Work

GLP-1 drugs are injectable medications that mimic a natural gut hormone called glucagon-like peptide-1, which signals fullness to the brain and slows how fast food leaves the stomach. They were originally developed for type 2 diabetes and later approved for chronic weight management [2][4].

Here’s the basic mechanism:

1. The drug binds to GLP-1 receptors in the pancreas, boosting insulin release when blood sugar rises.
2. It slows gastric emptying, so food sits in the stomach longer and you feel full sooner.
3. It acts on appetite centers in the brain, reducing hunger signals and food cravings [2][4].

This is why the same class of drug can treat diabetes (Ozempic, Mounjaro) and obesity (Wegovy, Zepbound) depending on the approved indication and dose. Choose a GLP-1 drug only after a clinician confirms it fits your health profile, since dosing and monitoring needs differ by condition [2].

How Much Does Wegovy Cost Without Insurance

Without insurance, Wegovy has historically carried a list price above $1,000 per month, but cash-pay options tied to TrumpRx.gov and Novo Nordisk’s direct discount programs have pushed real-world costs lower for many patients by late 2026 [1][9]. The exact price depends on dose strength and whether you buy through the federal portal, a manufacturer savings program, or a standard retail pharmacy.

Key factors that change your Wegovy price:

• Dose stage: Starting doses are typically priced the same as maintenance doses, but total monthly cost can shift if you need dose adjustments.
• Purchase channel: TrumpRx.gov and manufacturer direct-to-consumer programs tend to offer lower cash prices than a standard retail pharmacy without a coupon [1][9].
• Insurance status: If weight-loss coverage is denied, cash-pay programs become your main lower-cost option.

Common mistake: assuming your retail pharmacy automatically applies the lowest available price. Always ask your pharmacist whether a manufacturer savings card or the TrumpRx cash price would be cheaper than your insurance copay before paying out of pocket [1][10].

Ozempic Price Comparison: Current Costs

Ozempic price comparisons in 2026 show a similar pattern to Wegovy: list prices remain high, but Most-Favored-Nation pricing and new cash-pay channels have narrowed the gap for patients paying out of pocket [3][9]. Because Ozempic is FDA-approved for type 2 diabetes, insurance coverage tends to be broader than for weight-loss-only drugs, which often brings real-world costs down further for diabetic patients [10].

Three price checkpoints worth comparing before you fill a prescription:

• Insurance copay (if diabetes-approved use applies)
• Manufacturer savings card price (Novo Nordisk cash programs)
• TrumpRx.gov or MFN-adjusted cash price [1][3][9]

Edge case: if you’re prescribed Ozempic off-label for weight loss rather than diabetes, insurance is far less likely to cover it, pushing you toward the same cash-pay comparison shoppers use for Wegovy [10].

Is Zepbound Cheaper Than Wegovy, and What Does Mounjaro Cost Per Month

Zepbound has generally launched and remained priced slightly below or comparable to Wegovy in cash-pay programs, while Mounjaro’s monthly cost mirrors Zepbound’s since both are made by Eli Lilly using the same active ingredient, tirzepatide [9][10]. Exact rankings shift as manufacturers adjust direct-to-consumer pricing, so “cheaper” can depend on which discount program you’re using that month.

A simple way to think about it:

Drug	Maker	Approved Use	Active Ingredient
Wegovy	Novo Nordisk	Weight management	Semaglutide
Ozempic	Novo Nordisk	Type 2 diabetes	Semaglutide
Zepbound	Eli Lilly	Weight management	Tirzepatide
Mounjaro	Eli Lilly	Type 2 diabetes	Tirzepatide

Choose Zepbound over Wegovy if your clinician believes tirzepatide’s dual-hormone action will work better for your weight-loss goals and your cash-pay program makes it the lower-cost option that month [9][10]. Mounjaro cost per month tends to track closely with Zepbound’s because they’re chemically identical, just approved for different conditions [9].

Why Are GLP-1 Drugs So Expensive

GLP-1 drugs are expensive because they’re complex biologic injectables, protected by patents, developed through costly clinical trials, and marketed for conditions affecting tens of millions of Americans, which keeps demand and pricing power high [8][9]. Manufacturers have also priced US sales far above what they charge in other countries, a gap the Most-Favored-Nation policy specifically targets [3][7].

Three forces driving the historically high price tag:

• Patent protection: No generic competition exists yet for most GLP-1 formulations.
• Manufacturing complexity: Peptide-based injectables cost more to produce at scale than simple pills.
• International price gaps: US list prices have run multiples higher than prices in Europe or Canada for the same drug, which is the core issue MFN pricing aims to fix [3][7][8].

Common mistake: assuming lower list prices mean lower prices everywhere immediately. Price cuts from manufacturers and MFN deals are rolling out in phases through 2027, so not every pharmacy or plan reflects the new pricing yet [3][9].

Do Insurance Plans Cover Wegovy or Ozempic

Insurance coverage for Wegovy or Ozempic depends heavily on your plan type and the reason for the prescription: diabetes treatment is covered far more consistently than weight-loss treatment [10]. Medicare historically excluded weight-loss drugs, though MFN negotiations are reshaping what Medicare and Medicaid pay and cover going into 2027 [3][7].

What typically determines coverage:

• Diagnosis code: Type 2 diabetes claims (Ozempic, Mounjaro) get approved more often than obesity-only claims.
• Plan type: Employer plans vary widely; some explicitly exclude weight-loss drugs.
• Medicare/Medicaid rules: Coverage rules are evolving under new MFN agreements, so check current plan documents each year [3][7].

If your plan denies coverage, the cash-pay options through TrumpRx.gov or manufacturer savings programs become your main path to an affordable price [1][10]. For broader context on weight management options and support, see our weight loss resource hub.

Wegovy vs Ozempic vs Zepbound vs Mounjaro: What’s the Difference

The core difference between these four drugs comes down to active ingredient and FDA-approved use, not brand marketing. Wegovy and Ozempic both use semaglutide, while Zepbound and Mounjaro both use tirzepatide; Wegovy and Zepbound are approved for weight management, while Ozempic and Mounjaro are approved for type 2 diabetes [9][10].

Quick decision guide:

• Choose Wegovy or Zepbound if your primary goal is weight loss and you don’t have a diabetes diagnosis driving the prescription.
• Choose Ozempic or Mounjaro if you have type 2 diabetes and your doctor wants both blood sugar control and potential weight benefits.
• Zepbound vs Wegovy: tirzepatide (Zepbound) acts on two gut hormone receptors instead of one, which some patients and clinicians associate with stronger appetite suppression [9].

Common mistake: assuming any of these four drugs are interchangeable for insurance purposes. A plan that covers Ozempic for diabetes will not automatically cover Wegovy for weight loss, even though they share the same active ingredient [10].

GLP-1 Side Effects, Risks, and Who Shouldn’t Take Them

GLP-1 drugs commonly cause nausea, vomiting, diarrhea, and constipation, especially when starting or increasing a dose, and they carry specific warnings for people with a personal or family history of certain thyroid cancers [2][4]. These drugs are not appropriate for everyone, and a clinician should review your full medical history before prescribing.

Who should generally avoid GLP-1 drugs:

• People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2][4].
• People with a history of pancreatitis, who need extra caution and monitoring.
• Pregnant or breastfeeding individuals, since safety data in pregnancy is limited.

Edge case: if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction after an injection, stop and contact your prescriber right away rather than waiting for your next scheduled dose [2][4]. For general guidance on managing health conditions alongside new medications, our wellness resources and men’s health guidance or women’s health guidance can help you think through what questions to bring to your doctor.

Are There Cheaper Alternatives to GLP-1 Drugs

Cheaper alternatives to brand-name GLP-1 drugs exist, including older diabetes and weight-loss medications, lifestyle-based approaches, and in some cases compounded versions, though each comes with tradeoffs in effectiveness or regulatory oversight. No alternative matches the weight-loss results seen in GLP-1 clinical trials, but they can be reasonable bridges while you sort out insurance or cash-pay pricing [4][10].

Lower-cost options to discuss with a doctor:

• Metformin: a long-used, inexpensive diabetes drug with modest weight benefits.
• Older appetite suppressants: generally cheaper but with different side-effect profiles.
• Structured diet and exercise programs: no drug cost, though results are typically slower.

Choose a non-GLP-1 alternative if cost is a hard barrier and your doctor confirms your health profile doesn’t require the stronger effects of semaglutide or tirzepatide. Pairing any medication with sustainable habits, like the meals in our plant-based healthy recipes guide, can also support results regardless of which drug or alternative you choose.

How to Get GLP-1 Drugs Prescribed

Getting a GLP-1 drug prescribed starts with a conversation with your primary care doctor or an endocrinologist about your diagnosis, health history, and goals, since these drugs require a prescription and typically a prior authorization from insurance [2]. Telehealth platforms have also expanded access, though you’ll still need a documented medical reason for the prescription.

Typical steps:

1. Get bloodwork and a physical exam to confirm diagnosis (diabetes or qualifying BMI for weight-loss use).
2. Discuss your full medical history, including thyroid cancer family history and prior pancreatitis.
3. Ask your doctor to submit a prior authorization if your insurance requires one.
4. If denied or uninsured, compare cash-pay options through TrumpRx.gov or manufacturer savings programs before filling the prescription [1][2].

Common mistake: starting treatment through an unverified online source without a real medical evaluation. Legitimate GLP-1 prescriptions always involve a licensed clinician reviewing your health history first [2].

GLP-1 Weight Loss Results: How Much Weight Can You Expect to Lose

GLP-1 drugs have shown meaningful weight-loss results in clinical use, with tirzepatide-based drugs (Zepbound, Mounjaro) generally associated with larger average weight loss than semaglutide-based drugs (Wegovy, Ozempic) in published research, though individual results vary widely by dose, adherence, and lifestyle factors [4]. Results build gradually over months, not weeks.

What influences your results:

• Dose level: Higher maintenance doses are generally linked to greater weight loss.
• Time on treatment: Most meaningful results appear after several months of consistent use.
• Lifestyle factors: Diet quality and activity level still matter alongside the medication [4].

Decision rule: if you’re not seeing any change after a reasonable trial period at a stable dose, talk to your prescriber about whether a dose adjustment or a different GLP-1 drug makes sense rather than stopping treatment abruptly [2][4].

Common Mistakes People Make With GLP-1 Injections

The most common GLP-1 injection mistakes are skipping doses irregularly, injecting into the same exact spot repeatedly, and increasing the dose faster than prescribed to speed up results. Each of these can increase side effects or reduce how well the drug works [2].

Mistakes to avoid:

• Inconsistent timing: GLP-1 drugs work best on a steady weekly or daily schedule, depending on the drug.
• Same injection site every time: rotate between approved sites (abdomen, thigh, upper arm) to reduce irritation.
• Self-adjusting the dose: only a prescriber should change your dose, since faster increases raise the risk of nausea and vomiting.
• Running out and restarting at the old dose: restarting after a long gap without medical guidance can cause unexpected side effects [2].

Edge case: if you miss a dose by more than a few days, don’t just double up next time. Contact your prescriber or pharmacist for specific guidance based on your drug and dosing schedule [2].

Frequently Asked Questions

What is TrumpRx.gov and how does it affect GLP-1 prices? TrumpRx.gov is a federal website launched in February 2026 that connects patients to lower cash prices for brand-name drugs, including GLP-1 medications like Wegovy and Zepbound, by cutting out some traditional pricing middlemen [1][5].

How much does Wegovy cost without insurance right now? Wegovy’s list price has historically exceeded $1,000 per month, but cash-pay programs tied to TrumpRx.gov and manufacturer discounts have lowered real-world out-of-pocket costs for many uninsured patients by late 2026 [1][9].

Is Zepbound cheaper than Wegovy? Zepbound’s cash-pay price has often matched or come in slightly below Wegovy’s depending on the active discount program, since both drugs compete for the same patient base under evolving manufacturer pricing strategies [9][10].

What is Mounjaro’s cost per month compared to Ozempic? Mounjaro and Ozempic pricing differ by manufacturer and current discount programs, but both have seen downward pressure from Most-Favored-Nation agreements affecting Medicare, Medicaid, and some cash-pay channels [3][9].

Does insurance cover GLP-1 drugs for weight loss? Coverage for weight-loss use (Wegovy, Zepbound) is less consistent than coverage for diabetes use (Ozempic, Mounjaro), and Medicare/Medicaid rules are still evolving under new MFN pricing deals [3][7][10].

Why did the Trump administration target GLP-1 prices specifically? GLP-1 drugs were singled out because of their high cost and wide demand across both diabetes and obesity treatment, making them a visible test case for Most-Favored-Nation pricing policy [3][7][8].

Are compounded GLP-1 drugs a cheaper alternative? Compounded versions have been marketed as cheaper alternatives, but they fall outside the same FDA approval process as brand-name Wegovy, Ozempic, Zepbound, or Mounjaro, so quality and safety oversight can differ [4].

Who shouldn’t take GLP-1 medications? People with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, or a history of pancreatitis generally should not take GLP-1 drugs without specialist guidance [2][4].

Conclusion

Trump GLP-1 prices for Wegovy, Ozempic, Zepbound, and Mounjaro are genuinely shifting, but the savings roll out unevenly depending on your insurance, diagnosis, and which purchasing channel you use. TrumpRx.gov and the Most-Favored-Nation agreements with Novo Nordisk and Eli Lilly are the two biggest levers behind lower cash-pay and Medicare prices, with more price cuts expected through 2027 [1][3][9].

Your next step is practical: before filling or refilling a GLP-1 prescription, check three things. First, confirm whether your insurance covers the specific drug for your diagnosis. Second, compare your insurance copay against the current TrumpRx.gov cash price and any manufacturer savings card. Third, talk to your prescriber about dose, timeline expectations, and whether a lower-cost alternative fits your situation if cost remains a barrier. Prices and coverage rules are still moving, so it’s worth checking back every few months as the 2027 pricing changes take effect.

References

[1] Fact Sheet President Donald J Trump Launches Trumprx Gov To Bring Lower Drug Prices To American Patients – https://www.whitehouse.gov/fact-sheets/2026/02/fact-sheet-president-donald-j-trump-launches-trumprx-gov-to-bring-lower-drug-prices-to-american-patients/ [2] How Prescribed Glp 1 Ozempic Zepbound Mounjaro 3583061 – https://www.drugs.com/medical-answers/how-prescribed-glp-1-ozempic-zepbound-mounjaro-3583061/ [3] Fact Sheet President Donald J Trump Announces Major Developments In Bringing Most Favored Nation Pricing To American Patients – https://www.whitehouse.gov/fact-sheets/2025/11/fact-sheet-president-donald-j-trump-announces-major-developments-in-bringing-most-favored-nation-pricing-to-american-patients/ [4] Glp 1 Drug Best Weight Loss 3579236 – https://www.drugs.com/medical-answers/glp-1-drug-best-weight-loss-3579236/ [5] President Trump Launches Trumprx Gov Delivering Massive Immediate Savings To Millions Of Americans – https://www.whitehouse.gov/releases/2026/02/president-trump-launches-trumprx-gov-delivering-massive-immediate-savings-to-millions-of-americans/ [6] Dcpd 202600083 – https://www.govinfo.gov/content/pkg/DCPD-202600083/pdf/DCPD-202600083.pdf [7] Federal Update Trump Administration Announces Deal Bring Most Favored Nation Pricing Glp 1s – https://www.amcp.org/letters-statements-analysis/federal-update-trump-administration-announces-deal-bring-most-favored-nation-pricing-glp-1s [8] Czxk7k9nd11o – https://www.bbc.com/news/articles/czxk7k9nd11o [9] Novo Nordisk Cut Glp 1 Prices Tough Us Market – https://pharmaphorum.com/news/novo-nordisk-cut-glp-1-prices-tough-us-market [10] Wegovy Ozempic Zepbound Mounjaro Which Glp 1 Is Right For You And What Will It Cost – https://insiderx.com/blog/wegovy-ozempic-zepbound-mounjaro-which-glp-1-is-right-for-you-and-what-will-it-cost